Personalized Medicine in Oncology - <em>BRAF</em> Mutation in Colorectal Cancer<br> <h4>Anita Turk, MD; Dustin Deming, MD<br>Division of Hematology and Oncology,Department of Medicine<br>University of Wisconsin-Madison School of Medicine and Public ...
Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer
Colorectal Cancer – Treatments | Gastrointestinal Cancer
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer | Cancer Cell International | Full Text
Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer | Modern Pathology
![PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/50a4df542bd40adc614a990d8984a44bb22f05b5/3-Figure1-1.png "PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar")
PDF] Colorectal Cancer Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer | Semantic Scholar
Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches - ScienceDirect
Overview of molecular biomarkers in metastatic colorectal cancer. WT,... | Download Scientific Diagram
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review - Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de Gramont, 2015
Glimmers of Hope—New Strategies for Overcoming Treatment Resistance in Patients with BRAF V600E-mutated Metastatic Colorectal Cancer - touchONCOLOGY
BRAF Mutation and Its Importance in Colorectal Cancer | IntechOpen
Cells | Free Full-Text | KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study
Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers | Discover Oncology
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
Frontiers | Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines - Annals of Oncology
BRAF Mutation in Colorectal Cancer | IntechOpen
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer | Nature Medicine
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
Frequencies of RAS/BRAFV600E mutation subtypes. N = 152 (KRAS Exon2... | Download Scientific Diagram
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
